-
Adamas Pharmaceuticals Surges 30% Following Positive Phase 3 Results
Wednesday, December 23, 2015 - 9:49am | 184Shares of Adamas Pharmaceuticals Inc (NASDAQ: ADMS) spiked higher by more than 30 percent early Wednesday after the company announced positive top-line Phase 3 results of ADS-5102 for patients with Parkinson's Disease. Adamas Pharmaceuticals said that results from its randomized, placebo-...